Struggling with attention and organization as you age? It could be ADHD, not dementia

When people share concerns with their doctor about their memory, attention, or difficulty completing tasks, they may receive a diagnosis of mild cognitive impairment (MCI), a stage between normal aging and dementia. However, older adults with ADHD may never have received a diagnosis of ADHD, especially if they had learned skills to compensate during their…

Read More

Age matters: Paternal age and the risk of neurodevelopmental disorders in children

In other words, the older the parent, the increased risk a child has of developing disorders such as autism, ADHD and other learning disabilities. A research team from the Department of Developmental Neuroscience at the Tohoku University Graduate School of Medicine has revealed further details about this phenomenon with their recent publication in PLOS ONE.

Read More

Can Brain Scans Diagnose ADHD?

Brain imaging, using methods like Magnetic Resonance Imaging (MRI), electroencephalograph (EEG), and many others, is an important research area for ADHD. It’s also a “hot topic” with periodic excited claims in the media. The bottom line: brain imaging cannot diagnose ADHD or its subtypes.

Read More

Study finds Tai-Chi-based mindfulness training reduced core ADHD symptoms in children

In a recent study published in the Journal of Developmental & Behavioral Pediatrics, Stewart H. Mostofsky, M.D., director of the Center for Neurodevelopmental and Imaging Research at Kennedy Krieger Institute, and Karen E. Seymour, Ph.D., assistant professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine, found that a mindful movement (Tai-Chi)-based…

Read More

Can a Healthy Lifestyle Reduce ADHD Incidence in Children?

Children who follow key healthy lifestyle recommendations at age 10 and 11 are much less likely to be diagnosed with attention-deficit/hyperactivity disorder (ADHD) by age 14. In one of the first investigations of its kind, the study of more than 3000 fifth-grade students in Nova Scotia, Canada, showed that those who met at least seven…

Read More

ADHD Rates Up in Veterans

The number of veterans being diagnosed with attention-deficit/hyperactivity disorder (ADHD) is increasing, according to a study published in the March issue of Medical Care. Andrew C. Hale, Ph.D., from the VA Ann Arbor Healthcare System in Michigan, and colleagues investigated the prevalence and incidence of ADHD in people seeking care at all primary care and…

Read More

Students with learning disabilities tackle online instruction

The switch from in-person to online classes has been challenging for students with learning differences like dyslexia, ADHD and autism…Jeff Baier, Rochester’s Office of Disability Resources coordinator, said that multiple DRCs have seen an increase in need from students with disabilities across the University system. However, the centers also provide access to adaptive technologies to…

Read More

ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group

The coronavirus disease 2019 (COVID-19) pandemic is creating unprecedented challenges at every level of society. Individuals with neurodevelopmental disorders, such as attention-deficit hyperactivity disorder (ADHD), are particularly vulnerable to the distress caused by the pandemic and physical distancing measures, and they might display increased behavioural problems. The crisis also poses several important questions for clinicians…

Read More

Telemedicine is not enough

It’s 2020, and millions of Americans—now bound to their homes—still don’t have reliable internet access. In a pandemic, that’s a public health crisis.

Read More

Efficacy and safety of guanfacine extended-release in the treatment of attention-deficit/hyperactivity disorder in adults: Results of a randomized, double-blind, placebo-controlled study

This study was sought to investigate guanfacine extended-release (GXR) efficacy and safety in adults with attention-deficit/hyperactivity disorder (ADHD). Researchers designed a phase 3, double-blind, placebo-controlled study (conducted between October 2016 and July 2017) including Japanese patients aged ≥ 18 years with ADHD (DSM-5).

Read More